Pharmacokinetics of Leritrelvir(Ray1216) in Elder Participants

NCT06169085 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Elder

Interventions

DRUG: Leritrelvir

Sponsor

Guangdong Raynovent Biotech Co., Ltd